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Using Mortality Data to Estimate Radiation
Effects on Breast Cancer Incidence
by David G. Hoel*t and Gregg E. Dinse*
In this paper we combine Japanese data on radiation exposure and cancer mortality with U.S. data on
cancerincidenceandlethalitytoestimatetheeffects ofionizingradiationoncancerincidence. Theanalysis
is based on the mathematical relationship between the mortality rate andthe incidence andlethalityrates,
as well as on statistical models that relate Japanese incidence rates to U.S. incidence rates and radiation
risk factors. Our approach assumes that the risk of death from causes other than the cancer does not
depend on whether or not the cancer is present, and among individuals with the cancer, the risk ofdeath
attributable to the cancer is the same in Japan and the U.S. and is not affected by radiation exposure. In
particular, wefocus onthe incidence ofbreastcancerinJapanesewomenandhowthis incidence is affected
by radiation risk factors. The analysis uses Japanese exposure and mortality data from the Radiation
Effects Research Foundation study ofatomic bomb survivors and U.S. incidence and lethality data from
the Surveillance, Epidemiology, and End Results Registry. Even without Japanese incidence data, we
obtain reasonable estimates ofthe incidence ofbreast cancer in unexposed Japanese women and identify
the radiation risk factors that affect this incidence. Our analysis demonstrates that the age at exposure
is an important risk factor, but that the incidence ofbreast cancer is not affected by the city ofresidence
(Nagasaki versus Hiroshima) or the time since exposure.
Introduction
The relationship between ionizing radiation and can-
cermortalityisfairlywellunderstood. Quantitative risk
models have been developed to assess the impact of
environmental and occupational levels ofionizing radia-
tion on cancer mortality and to establish radiation ex-
posure standards (1,2). The epidemiological data on
which this work has been based are primarily the mor-
tality data from follow-up studies of atomic bomb sur-
vivors (3-7) and several large medical cohorts, such as
patients withankylosingspondylitis (8). Boththe cancer
mortality data and the exposure data have been ofsuf-
ficient qualitytoenablethemodelingofcancermortality
rates.
Recently the emphasis of quantitative risk assess-
ment has shifted from cancer mortality to cancer inci-
dence as researchers have become aware ofthe need to
assess the relationship between ionizing radiation and
the onset of cancer (9). The primary impediment to the
development ofquantitative incidence modelsisthelack
of tumor registries with complete coverage and high-
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qualitydataonradiationexposureand cancerincidence.
Furthermore, though some analyses have used tumor
registry datafrom Nagasakialone (5-7), there havenot
been any analyses of cancer incidence data from both
Hiroshima and Nagasaki.
Ouranalysis combinesJapanese data onradiation ex-
posure and cancer mortality with U.S. data on cancer
incidence and cancer lethality to estimate the effects of
ionizing radiation on cancer incidence. This approach is
based on standard likelihood techniques, the mathe-
matical relationship between the mortality rate and the
incidence and lethality rates, and statistical models re-
lating the Japanese incidence rates to both the U.S.
incidence rates and various radiation risk factors. We
focus on estimating the incidence of breast cancer in
Japanese women and identifying the radiation risk fac-
tors that influence a woman's chances of developing
breast cancer.
Methods
Definitions
The cancer incidence rate, the cancer mortality rate,
and the cancer lethality rate are three important de-
scriptors of the cancer onset/death process. Suppose
that age is grouped into J intervals and let Ij, Mj, and
Ljk denote the incidence rate, the mortality rate, and
the lethality rate associated with breast cancer (1
- k
s j
- J). Among all women surviving to the beginningHOEL AND DINSE
ofthejth interval, Ij represents the risk ofdeveloping
breast cancer in thejth interval, M-represents the risk
of dying due to breast cancer in the jth interval, and
Ljk is a conditional mortality rate that represents the
rnsk of dying due to breast cancer in the jth interval,
given the cancer was diagnosed in the kth interval. The
incidence rate, themortalityrate, and the lethalityrate
are discrete hazard rates that correspond to the distri-
butions ofage at breast cancer onset, age at death due
to breast cancer, and time from breast cancer onset to
death due to breast cancer, respectively.
Assumptions
The proposed methods rely on three assumptions.
First, weassumethatthecancerlethalityratesinJapan
and the U.S. are the same. The distribution of ages at
which women develop breast cancer (I) can differ be-
tween Japan and the U.S., as can the distribution of
ages at which women die due to breast cancer (Mj), but
among women diagnosed with breast cancer the risk of
death due to cancer (Ljk) does not depend on their na-
tionality. Second, we assume that risk factors related
to radiation exposure do not affect the cancer lethality
rate, although these risk factors can affect the cancer
incidence rate and hence the cancer mortality rate.
Third, we assume that the risk of death from causes
other than breast cancer does not depend on whether
or not breast cancer is present.
Breast Cancer Lethality
Among all women diagnosed with breast cancer in
the kth interval, let Cjk denote the number who died
duetobreast cancerinthejthintervalandletbjk denote
the number who died due to other causes (or were lost
to follow-up) in thejth interval. Apart from constants
ofproportionality, thelog-likelihood ofthebreastcancer
lethalitydatacanbeexpressedintermsoftheLjkvalues
as follows:
J J I-
AL = EE Cjk log(Ljk) (1)
+ (bik + Cik)
- Cjk log(l - Ljk)}
Maximum likelihood (ML) estimates of the Ljk values
can be derived by maximizing AL.
Recall that the lethality rate, L,k, is the probability
ofdeath due to breast cancer in thejth interval, given
that the cancer was diagnosed in the kth interval and
the woman was alive just before thejth interval (1 £
k £j £ J). Ifthefollow-up period for women diagnosed
with breast cancer is relatively short, a yearly lethality
rate would provide much more information than one
based on intervals of several years. For example, if
women are followed for up to 12 years after diagnosis,
then typically they contribute to the estimation ofonly
a few 5-year lethality rates.
Let Gik denote the yearly lethality rate, which is de-
fined as the probability of death due to breast cancer
at age i, given that the cancerwas diagnosed in the kth
interval and the woman was alive at age i-1. It can be
shown thatLjk and Gik are related as follows:
1 - Ljk = H (1 - Gk),
i (2)
where the product is over all ages i in thejth interval.
Apart from constants, the log-likelihood of the yearly
lethality data (conditioned on the grouped diagnosis
data) is KG = Yak=1 XG(k), where
XG(k) = E> ciklog(Gik) j=k i
+ (bhk + chk)
- cik] log(l
- Gik)} (3)
Among the women diagnosed with breast cancer in the
kth interval, cik denotes the number who died due to
breast cancer at age i and bik denotes the number who
died due to other causes (or were lost to follow-up) at
age i. The ML estimates ofthe Gik values are obtained
by maximizing AG and the Ljk values can be estimated
from the ML estimates of the Gik values by using
Eq. (2).
We focus on three ways of estimating the yearly
breast cancer lethality rates. First, in the absence of
any parametric modeling assumptions, the nonpara-
metric ML estimate of each Gik is
#{death due to breast
A~k= cancer at age i}
Gik
=
#{alive at age i - 1 with breast '
cancer diagnosed in interval k}
(4)
where #{E} denotes the number of women for whom
eventEistrue. Practicallyspeaking, thenonparametric
analysis can be viewed as a fully saturated parametric
analysis in the sense that a separate value of the le-
thality rate is estimated foreach combinationofthe age
at death and the intervals for age at diagnosis. Second,
in order to reduce the number ofquantities to be esti-
mated, we can specify a parametric model for the Gik
values, such as the following logistic model (10):
2
log{Gik I (1 - Gik)} = E (i - ak + 1) *p p=O (5)
where ak is the earliest age in the kth interval. This
model assumes that the logit of the lethality rate is a
quadratic function of the time since diagnosis. For all
women diagnosed with breast cancer in the kth com-
ponent ofthe log-likelihood, XG(k), can be maximized as
afunction oftheparametersip (p = 0,1,2), and foreach
k the ML estimate of Gik is calculated by substituting
the ML estimates of the 4ip values into Eq. (5). Third,
for all women with breast cancer, KG can be maximized
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as a function of the parameters Ppq (p = 0,1,2; q =
0,1,2) under the logistic model:
log{Gik / (1
- Gik)}
=
2 2
E E (i - ak + 1)P a%Jpq, (6)
p=o q=O
which assumes that the lethality rate is a quadratic
(logistic) function of the age at diagnosis and the time
since diagnosis. In this case, a total ofonly nine param-
eters (i.e., the 1pq values) need to be estimated. Each
Gik is estimated by substituting the ML estimates of
the *pq values into Eq. (6).
Breast Cancer Mortality and Incidence
We assumed a piecewise Exponential model for the
breast cancer mortality rates, which allows theMj val-
ues tovarywith age (acrossintervals) eventhoughthey
are constant within intervals. The log-likelihood ofthe
breast cancer mortality data under the piecewise Ex-
ponential model is
kM = > {c1log(Mi) - r1M,}, (7) ij=1
where cj = cjk is the number of women who died
due to breast cancer duringthejth interval and rjis the
number ofperson-years at risk observed during thejth
interval. Dinse and Hoel (manuscript in preparation)
demonstrate that the cancer mortality rate can.be ex-
pressed asthefollowingfunction ofthe cancerincidence
rates and the cancer lethality rates:
Mi
=
i k-1
k=l i=l
i)}Ik {n (1 -Lik) Lk
i j k-1 ] j-1 . V
_1 - Ii) + E H1 Ii) Ik {(1 - Lik)}
i=l ~~k=1 -i=l J i=kJ
Therefore, the log-likelihood kM can be expressed as a
function ofthe Ii values (and theLik values), say XI, by
substituting Eq. (8) forMj in Eq. (7). Estimates ofthe
Iivalues canbe obtained byfirstreplacingtheLikvalues
with their estimates and then maximizing KI as a func-
tion of the Ii values.
Linking U.S. and Japanese Incidence
Rates
In order to relate the breast cancer incidence rates
inJapan and the U.S., we specified the followingmodel:
1 - 1JAPAN = (1 - 1USA)e(o +1 j (9)
wheretjisthemidpointofthejth ageinterval. Wemake
no parametric assumptions about the form of the inci-
dence rates themselves, only the way in which 1JAPAN
relates to IUSA. Based on a first-order approximation,
Eq. (9) can be viewed as a discrete analog ofthe pro-
portional hazards model in which the ratio ofU.S. and
Japanese incidence rates is a log-linear function ofage.
Estimating Baseline Incidence in Japan
Theincidence ofbreastcancerinunexposedJapanese
women can be estimated as follows. Express X, as a
function of IJJAPAN, Ljk, and the Japanese mortality
data. Replace the Ljk values with the ML estimates
obtained from the U.S. lethality data and use Equation
(9) to express IJJAPAN in terms of JUSA 4k, and 41.
Estimate1jUSA fromthe U.S. incidence data as follows:
AUSA -
I.
#{diagnosed with breast cancer
in thejth interval} (10)
#{alive without breast cancer upon
entering thejth interval}
Ifwe treat the estimates ofthe U.S. lethality and base-
line incidence rates as known, an estimate of the Jap-
anese baseline incidencerate,,1JAPAN, canbecalculated
by maximizing XI as a function only of 4o and 41 and
then substituting the estimates ofIj A, 0 and +1 into
Eq. (9).
Linking Incidence to Radiation Exposure
In order to relate information on radiation dose (D)
and a vector ofcovariates or exposure variables (Z) to
the breast cancer incidence in Japanese women, we
specified the following model:
1 - IJAPAN (DJZ) = (1 - IAPAN)1+DeOz , (11)
where 0isavectorofparameters, IJJAPAN isthebaseline
breast cancer incidence rate, and I 1'AN (D,Z) is the
breast cancer incidence rate for women who were ex-
posed to dose D with covariate vector Z. Based on a
first-order approximation, Eq. (11) can be viewed as a
discrete analog of the relative risk model in which the
ratio ofincidence rates for exposed and unexposed Jap-
anese women is a simple linear function ofdose and an
exponentiated covariate term.
Analyzing Radiation Effects on Incidence
The first step is to categorize the covariates. Next,
assume that the cancer mortality function is piecewise
Exponential with a different value, Mi, forthe ith com-
bination of the various covariate categories and the J
age-at-death intervals. The log-likelihood ofthe data on
cancer mortality and radiation exposure is
M= {ci log(Mi) - riMi,
i (12)
where ci is the number of women in the ith category
who died due.to breast cancer and ri is the number of
person-years at risk observed in the ith category. Re-
writethislog-likelihood asafunction ofIJAPAN
(D,Z), andLUk, saye,, by replacing each Mi in Eq. (12)
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byamodification ofEq. (8)inwhichwesubstitute either
I^:APA orlJAPAN (D,Z) for Ij, depending on whether
or not the exposure occurred after thejth age interval.
A 10-year latency period was incorporated by including
the covariate terms only for the age intervals that ex-
ceeded the age at exposure by at least ten years. Re-
place the Ljk values with the ML estimates obtained
from the U.S. lethality data and use Eq. (11) to express I4JAPAN (D,Z) in terms ofIJAPAN and 0. Treat the es-
timates ofthe lethality and baseline Japanese incidence
rates as known so that4I: reduces to afunction inwhich
only 0 is unknown. An estimate of the Japanese inci-
dence rate, JAPAN (D,Z), can be obtained by maxi-
mizing XA as a function of 0 and then substituting the
estimates of IJJAPAN and 0 into Eq. (11).
The importance ofvarious exposure variables can be
assessed by means ofthe likelihood ratio test (11). The
likelihood ratio statistic is equal to twice the difference
between the maximized values ofA,formodels with and
without the exposure variable(s) of interest. The sig-
nificance level (p-value) associated with the exposure
variable(s) is obtained by comparingthe likelihood ratio
statistic to the percentage points ofthe chi-squared dis-
tribution. The number ofdegrees offreedom equals the
difference in the numbers of parameters estimated in
the two models.
Results
Sources of Data
We obtained data on breast cancer incidence and le-
thality for unexposed U.S. women from the Surveil-
lance, Epidemiology, and End Results (SEER) Regis-
try (12). The SEER Registry gives information on
women diagnosed with breast cancer between 1973 and
1984, as well as follow-up data onthese women overthe
12-yearperiod from 1973to 1985. Formorethan 125,000
women diagnosed with breast cancer, the SEER Re-
gistry provides the age at diagnosis, the age at the last
follow-up visit, and an indicator ofwhether the woman
was dead or lost to follow-up (e.g., still alive). If the
woman died, the registry also gives the age at death
and a cause-of-death indicator.
Weused dataonradiationexposure andbreast cancer
mortality for Japanese women from the Radiation Ef-
fects Research Foundation (RERF) Life Span Study
(3,4). This study consists of a cohort of atomic bomb
survivors followed since 1950, with each individual hav-
ing a calculated radiation exposure that depends on dis-
tance and shielding. The women in the RERF study
have contributed approximately 1.35 million person-
years at risk; there have been more than 15,000 deaths,
including 155 deaths due to breast cancer. Radiation
dose is measured in milligrays (mGy) and represents
the total free-in-air kerma. There are three exposure
variables: city (1 = Hiroshima, 2 = Nagasaki), age at
exposure, and time since exposure. The data on age at
exposure, time since exposure, and attained age are
recorded in 5-year intervals. For the ith combination of
city, age at exposure, time since exposure, and attained
age, the data set gives the number of person-years at
risk (ri), the number ofdeaths due to breast cancer (ci),
and the mean radiation dose (Di).
Breast Cancer Lethality
The women in the SEER study were followed for, at
most, 12 years; thus we chose to model the yearly le-
thality rates (i.e., the Gik values) rather than the le-
thality rates corresponding to the 5-year intervals (i.e.,
the Ljk values). As described earlier, the Gik values
were estimated inthree ways. First, the nonparametric
ML estimate in Eq. (4) was calculated for each of the
168 combinations of the 12 years of follow-up and the
14 intervals for age at diagnosis. Second, the three pa-
rameters in Eq. (5) were estimated separately for each
ofthe 14 age-at-diagnosis intervals, giving in a total of
42estimates. Third, thenineparametersinEq. (6)were
estimated on the basis of all the data.
These three sets ofbreast cancer lethality estimates
are plotted in Figure la-c. For each age-at-diagnosis
interval k, the ML estimates ofthe Gik values are plot-
ted against the number of years since diagnosis. For
womendiagnosedbeforeage60, thebreastcancerdeath
rateinitiallytends toincrease as afunctionoftime since
diagnosis and then decreases toward zero, with a peak
between 2 and 4 years after diagnosis. For women di-
agnosed at or after age 60, the breast cancer death rate
seems to steadily decrease with time since diagnosis.
The three figures suggest that Eq. (6) is adequate for
summarizing the yearly lethality rates because the es-
timates based on the 9-parameter model provide
roughly the same information as those based on the 42-
parameter or 168-parametermodels. TheLjk values can
be estimated by substituting the ML estimates of the
Gik values into Eq. (2).
Baseline Incidence
In order to estimate the baseline incidence of breast
cancer in U.S. women, we applied Eq. (10) to the data
from the SEER Registry. The resulting estimate of
each IjUSA, multiplied by 100,000 and rounded to the
nearest integer, is listed inTable 1 and plotted on alog-
scale in Figure 2. The incidence offemale breast cancer
in the U.S. is negligible for women under 25, increases
rapidly for women between 25 and 60, and then begins
to level off for women over 60.
In order to estimate the baseline incidence ofbreast
cancer in Japanese women, we treated the mortality
data in the lowest radiation exposure group in the
RERF study (i.e., 0-4mGy) as baseline mortalitydata.
Next, we used these data to construct XA, treated the
estimates of jUSA andL1k as fixed, and then maximized
XA as a function of 4O and 41. The resulting estimates
were: 4) = -0.1467and j = -0.0279. The correspond-
ing estimate ofeach IJAPAN, which is obtained by sub-
stituting 4O and 41 into Eq. (9), is listed in Table 1 and
plottedinFigure2. Forcomparisonpurposes, published
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FIGURE 1. Breast cancer lethality. The rate of death due to breast
cancer, conditional on the cancer being diagnosed in a particular
age interval, isplotted againstthe numberofyears since diagnosis
for each of 14 age-at-diagnosis groups. (a) Depicts the nonpara-
metric estimates, (b) depicts the parametric estimates derived
fromfitting a separate quadratic logistic model tothe dataforeach
age-at-diagnosis group, and (c) depicts the parametric estimates
derived fromfitting asingle logistic modelthatisquadratic inboth
the age at diagnosis and the time since diagnosis.
estimates (13) ofthe incidence rates ofbreast cancer for
women in three Japanese prefectures (Osaka in 1973-7;
Fukuoka in 1974-5; Miyagi in 1973-7) are also listed in
Table 1 and plotted in Figure 2.
The most notable feature of Table 1 and Figure 2 is
that the incidence ofbreast cancer in Japanese women
is much lower than in U.S. women. The breast cancer
incidence in Japan peaks at a level that is roughly an
order of magnitude less than the highest incidence in
the U.S. and then, in contrast to the U.S. incidence,
appears to decrease slightly in the older age groups.
The otherremarkable result is that ourestimates ofthe
Japanese incidence rates, which are based onJapanese
mortality data, U.S. incidence and lethality data, and
the simple log-linear model in Eq. (9), are very similar
to the observed incidences of breast cancer in Osaka,
Fukuoka, and Miyagi.
Radiation Effects
We evaluated the effect of ionizing radiation on the
incidence of breast cancer in Japanese women through
Table 1. Age-specific incidence of breast cancer among
unexposed women.
Breast cancer incidence per 100,000 unexposed women
Japan
United Our
Age interval Statesa Osakab Fukuokab Miyagib estimate
0-4 0 0 0 0 0
5-9 0 0 0 0 0
10-14 0 0 0 0 0
15-19 0 0 0 0 0
20-24 1 0 1 1 1
25-29 9 2 4 3 4
30-34 29 7 13 14 10
35-39 70 15 16 20 21
40-44 121 25 38 39 32
45-49 181 39 47 54 41
50-54 205 41 42 58 41
55-59 251 35 49 40 44
60-64 297 35 41 42 45
65-69 336 38 39 51 44
70-74 366 35 33 55 42
75-79 386 37 28 33 38
80-84 390 37 31 36 34
'U.S. rates were obtained by applying Eq. (10) to the data from
the SEER Registry (12).
bJapanese rates were obtained from the IARC data (13).
the use ofEq. (11). The log-likelihood XIwas expressed
as a function of the U.S. lethality rates, the Japanese
baseline incidence rates, and the parameter vector 0.
We then substituted the Japanese mortality data into
X, treated the estimates of L, and IjJA as fixed,
and maximized A,with respectto the elements of0. The
effects ofthe exposure variables were assessed by com-
paring differences in the values oftwice the maximized
log-likelihoods, which are listed in Table 2 for various
combinations ofthe exposure variables. In every case,
thefirstelementofthecovariate vectorZistheconstant
1, which allows for a simple dose effect.
Table 2 illustrates that age at exposure was the pri-
mary predictor of breast cancer incidence among ex-
posed women; the incidence rate decreased as the age
at exposure increased. In fact, the relevant information
was captured by simply dichotomizing age at exposure
intotwo groups: womenunderage20 and women ofage
20 or older. Further partitioning ofthe age at exposure
into three groups (ages 0-19, 20-49, 50+) did notyield
a significant improvement. As for the other covariates,
city seemed to have no effect at all, and time since
exposurehad aminimaleffect;theincidenceratetended
to increase with the time since exposure, but the in-
crease was not statistically significant.
Conclusions
We have shown that by borrowing information on
cancer incidence and cancer lethality in the U.S. from
the SEER data, age-specific cancer incidence rates in
Japan can be estimated fromJapanese cancer mortality
data. Infact, ourmethodsproducedverygoodestimates
of the Japanese incidence rates of breast cancer, even
thoughtheincidence ofbreastcancerintheU.S. ismuch
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FIGURE 2. Baseline breast cancer incidence. The baseline incidence
ofbreast cancer is plotted against age for women in the U.S. and
Japan. The plain solid line depicts the general incidence rate in
the U.S.; the lines connected by open squares, circles, and tri-
angles depict the incidence rates in the Japanese prefectures of
Osaka, Fukuoka, and Miyagi; and the dashed line depicts our es-
timate of the general incidence rate in Japan.
Table 2. Regression analysis ofthe effect ofvarious exposure
variables on the incidence of breast cancer in Japanese women.a
Exposure variables -2 Log-likelihood p-valueb
Constant 3036.20
Constant, city 3036.18 0.888
Constant, time since exposure 3035.53 0.413
Constant, age at exposure 3030.30 0.015
Constant, I {age at exposure 2 20}c 3029.61 0.010
Constant, I {age at exposure
- 20},
I {age at exposure > 50} 3028.89 0.026
aAssuming a 10-year latency period for the exposure effects.
bSignificance level associated with the likelihood ratio test which
compares a model involving one or more exposure variables with the
model involving only the constant term.
cI {E} is an indicator varible which equals one if event E is true
and 0 otherwise.
greater than in Japan. The accuracy of the incidence
estimatesprovides supportforourassumptionofsimilar
U.S. and Japanese breast cancer lethality rates. Cur-
rently we are refiningthe model forthe cancer lethality
rates, and we are in the process of applying our tech-
nique to other cancer sites.
The second aspect of this work is the application of
statistical models that estimate cancer incidence in-
duced by radiation. This approach permits incidence-
based radiation risk estimation, even without adequate
cancer incidence data. We are applying our modeling
technique to various cancer sites and will compare our
incidenceestimateswithotheravailableestimates, even
those based on direct estimation from actual incidence
data.
The Japanese data on radiation and cancer mortality have been
obtained from the Radiation Effects Research Foundation (RERF)
in Hiroshima, Japan. RERF is a private foundation that is funded
equally bytheJapanese Ministry ofHealth and Welfare and the U.S.
Department of Energy through the U.S. National Academy of Sci-
ences. The conclusions reached in this report are those ofthe authors
and do not necessarily reflect the scientificjudgment ofRERF or its
funding agencies. The authors thank RERF for the use oftheir data
and Frank DiIorio for his assistance with much ofthe computer pro-
gramming.
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